Monomethyl Fumarate
Neuroepithelial Tumor
Montefiore Medical CenterSmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Neuroepithelial Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM St. Jude Children's Research Hospital | Phase 1 | CCC |
gsk1120212 St. Jude Children's Research Hospital | Phase 1 | CC |
Sonidegib St. Jude Children's Research Hospital | Phase 1 | CC |
Ribociclib St. Jude Children's Research Hospital | Phase 1 | CC |
ETOPOSIDE Montefiore Medical Center | Early Phase 1 | C |
View all 13 →
Same molecule, other indications
Monomethyl Fumarate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →